1-17333979-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012387.3(PADI4):c.310G>A(p.Val104Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000476 in 1,613,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012387.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PADI4 | NM_012387.3 | c.310G>A | p.Val104Ile | missense_variant | 3/16 | ENST00000375448.4 | NP_036519.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PADI4 | ENST00000375448.4 | c.310G>A | p.Val104Ile | missense_variant | 3/16 | 1 | NM_012387.3 | ENSP00000364597 | P1 | |
PADI4 | ENST00000375453.5 | c.310G>A | p.Val104Ile | missense_variant | 3/4 | 2 | ENSP00000364602 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152126Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000290 AC: 73AN: 251460Hom.: 0 AF XY: 0.000243 AC XY: 33AN XY: 135912
GnomAD4 exome AF: 0.000496 AC: 724AN: 1460842Hom.: 0 Cov.: 29 AF XY: 0.000476 AC XY: 346AN XY: 726812
GnomAD4 genome AF: 0.000289 AC: 44AN: 152244Hom.: 0 Cov.: 30 AF XY: 0.000228 AC XY: 17AN XY: 74442
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2021 | The c.310G>A (p.V104I) alteration is located in exon 3 (coding exon 3) of the PADI4 gene. This alteration results from a G to A substitution at nucleotide position 310, causing the valine (V) at amino acid position 104 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at